Guobang Pharma Ltd.

SSE:605507.SS

20.53 (CNY) • At close June 9, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 1,440.0561,472.6921,525.7911,541.2551,338.7031,295.9711,243.7571,399.5581,410.1631,607.5761,409.881,527.371,176.0981,292.149970.8051,100.131,142.2661,059.9041,014.8461,232.281899.287
Kosten van de omzet 1,059.331,156.1041,138.8931,173.754971.4611,042.948936.6971,082.5721,034.9011,198.9421,042.831,092.474810.636928.669666.378751.111801.464729.852641776.02608.58
Brutowinst 380.726316.588386.897367.501367.242253.023307.06316.985375.261408.634367.05434.897365.462363.48304.427349.02340.802330.052373.845456.261290.707
Brutowinstmarge 0.2640.2150.2540.2380.2740.1950.2470.2260.2660.2540.260.2850.3110.2810.3140.3170.2980.3110.3680.370.323
Onderzoek- en ontwikkelingskosten 38.73854.76467.32852.29737.65527.7565.32350.58146.85762.48248.45354.95231.65549.0637.77435.47532.96340.2634.34838.87323.705
Algemene en administratieve kosten 84.761-138.363180.612-30.22675.746-126.169182.472-29.24676.324-117.776167.884-23.85965.253-94.10769.14897.47619.053-88.95858.59247.64942.906
Verkoop- en marketingkosten 17.759-5.02230.89615.01817.22720.34721.3617.1515.34225.00313.4510.90814.7920.69421.55318.84914.76919.12116.81223.42615.528
Verkoop-, algemene en administratieve kosten 102.52-143.38595.34280.17892.974-105.822203.832-12.09691.666-92.773181.334-12.9580.045-93.41390.7116.32433.823-69.83775.40471.07558.434
Overige kosten -9.009184.089-93.426-35.708-2.08210.1321.13-3.6376.452206.604-77.93290.1073.085-5.9966.75-1.974-0.7727.73-0.3054.301-4.405
Bedrijfskosten 132.24895.468185.409168.183133.667129.342168.149150.718144.975176.313151.856132.109114.785122.256132.032119.619105.079108.722113.51114.48584.14
Bedrijfsresultaat 248.478221.12201.488199.318236.105138.288146.46186.965230.551212.546261.713339.033239.587211.692157.313218.538221.232178.887227.423338.695191.111
Bedrijfsresultaat ratio 0.1730.150.1320.1290.1760.1070.1180.1340.1630.1320.1860.2220.2040.1640.1620.1990.1940.1690.2240.2750.213
Totaal overige inkomsten en kosten netto 0.352.218-0.945-6.288-2.082-0.190.185-2.692-1.918-7.3420.588-5.718-4.484-5.9966.75-1.974-0.7727.73-0.3054.301-4.405
Inkomen voor belasting 248.829223.337200.543229.824234.024138.098146.644184.273228.633205.203262.301333.032235.103205.696164.062216.564220.46186.617227.119342.996186.706
Inkomen voor belasting ratio 0.1730.1520.1310.1490.1750.1070.1180.1320.1620.1280.1860.2180.20.1590.1690.1970.1930.1760.2240.2780.208
Belastingkosten 34.56921.39826.27424.27535.44515.77515.84522.38833.6625.93735.9438.34434.79721.11520.44523.89135.10113.89535.64157.96925.643
Nettowinst 214.977202.71174.287205.867198.731123.391131.602162.841194.629199.84226.026294.644200.395184.947143.393192.59185.1172.745190.631285.286161.339
Nettowinstmarge 0.1490.1380.1140.1340.1480.0950.1060.1160.1380.1240.160.1930.170.1430.1480.1750.1620.1630.1880.2320.179
WPA (Winst Per Aandeel) 0.380.360.320.370.360.220.240.290.350.360.410.530.360.330.30.410.390.360.40.60.34
Verwaterde WPA 0.380.360.320.370.360.220.240.290.350.360.410.530.360.330.30.410.390.360.40.60.34
EBITDA 254.445228.98207.405340.076345.043224.139239.854266.307312.243280.24342.389395.091296.998237.069185.424278.057236.192208.055234.117386.992225.697
EBITDA ratio 0.1770.1550.1360.2210.2580.1730.1930.190.2210.1740.2430.2590.2530.1830.1910.2530.2070.1960.2310.3140.251